Revolutionizing Lupus Care with Advanced Predictive Blood Testing

Revolutionizing Lupus Care with Advanced Predictive Blood Testing

AMPEL BioSolutions introduces LuGENE®, a cutting-edge blood test poised to revolutionize the management of systematic lupus erythematosus (SLE). LuGENE® leverages predictive artificial intelligence (AI) to detect genetic biomarkers indicative of inflammation-driven SLE flares, offering clinicians valuable insights for tailored treatment strategies.

read more
New Blood Test Poised to Revolutionize Care for Systemic Lupus Erythematosus

New Blood Test Poised to Revolutionize Care for Systemic Lupus Erythematosus

AMPEL BioSolutions announced the launch of LuGENE®, an exciting breakthrough innovation in systematic lupus erythematosus (SLE) care. LuGENE® is a new blood test designed to predict SLE flares before they happen and provide specific information about each individual’s disease abnormalities, leading to faster, evidence-based treatment.

read more
LuGENE® Lupus Test Launches to Predict Flares & Drug Targets

LuGENE® Lupus Test Launches to Predict Flares & Drug Targets

AMPEL BioSolutions announces a breakthrough in personalized precision medicine that will revolutionize the way doctors manage the autoimmune disease Lupus.  Revealed in the peer-reviewed journal Genome Medicine and being made available to patients through a US follow-on study, the LuGENE® blood test forecasts patient flares and drug targets from gene expression utilizing predictive AI.

read more

Pin It on Pinterest